Literature DB >> 30027389

Co-occurring reasons for medication nonadherence within subgroups of patients with hyperlipidemia.

Dan V Blalock1,2, Hayden B Bosworth3,4,5,6, Bryce B Reeve5, Corrine I Voils7,8.   

Abstract

Medication nonadherence is a significant clinical problem among individuals taking statins. Poor adherence is often attributable to several reasons, yet most adherence interventions target a single reason. Baseline data were examined from a randomized clinical trial of 236 patients with hyperlipidemia. A latent class analysis was then performed on patients reporting any nonadherence (n = 109). A 4-class solution provided the most optimal fit and differentiation of classes. Class 1 (N = 59, 54%) included patients who reported occasionally forgetting. Class 2 (N = 16, 14%) represented patients who were concerned about side effects. Class 3 (N = 17, 16%) represented patients who reported out-of-routine life events as contributing to nonadherence. Class 4 (N = 17, 16%) represented patients who endorsed a large number reasons indiscriminately. Class membership was almost uniformly unrelated to any patient demographic factors or treatment arm. Each cluster of reasons defining these patients may be best addressed through different intervention strategies.

Entities:  

Keywords:  Latent class analysis; Medication nonadherence; Reasons; Self-report

Mesh:

Substances:

Year:  2018        PMID: 30027389     DOI: 10.1007/s10865-018-9954-3

Source DB:  PubMed          Journal:  J Behav Med        ISSN: 0160-7715


  23 in total

Review 1.  Adherence to medication.

Authors:  Lars Osterberg; Terrence Blaschke
Journal:  N Engl J Med       Date:  2005-08-04       Impact factor: 91.245

2.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Neil J Stone; Jennifer G Robinson; Alice H Lichtenstein; C Noel Bairey Merz; Conrad B Blum; Robert H Eckel; Anne C Goldberg; David Gordon; Daniel Levy; Donald M Lloyd-Jones; Patrick McBride; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Karol Watson; Peter W F Wilson
Journal:  J Am Coll Cardiol       Date:  2013-11-12       Impact factor: 24.094

Review 3.  Cholesterol lowering in the management of coronary artery disease: the clinical implications of recent trials.

Authors:  D A Eisenberg
Journal:  Am J Med       Date:  1998-02-23       Impact factor: 4.965

Review 4.  Interventions to improve adherence to lipid-lowering medication.

Authors:  Mieke L van Driel; Michael D Morledge; Robin Ulep; Johnathon P Shaffer; Philippa Davies; Richard Deichmann
Journal:  Cochrane Database Syst Rev       Date:  2016-12-21

5.  Effect of Reminder Devices on Medication Adherence: The REMIND Randomized Clinical Trial.

Authors:  Niteesh K Choudhry; Alexis A Krumme; Patrick M Ercole; Charmaine Girdish; Angela Y Tong; Nazleen F Khan; Troyen A Brennan; Olga S Matlin; William H Shrank; Jessica M Franklin
Journal:  JAMA Intern Med       Date:  2017-05-01       Impact factor: 21.873

Review 6.  A new taxonomy for describing and defining adherence to medications.

Authors:  Bernard Vrijens; Sabina De Geest; Dyfrig A Hughes; Kardas Przemyslaw; Jenny Demonceau; Todd Ruppar; Fabienne Dobbels; Emily Fargher; Valerie Morrison; Pawel Lewek; Michal Matyjaszczyk; Comfort Mshelia; Wendy Clyne; Jeffrey K Aronson; J Urquhart
Journal:  Br J Clin Pharmacol       Date:  2012-05       Impact factor: 4.335

7.  Telemedicine cardiovascular risk reduction in veterans: The CITIES trial.

Authors:  Hayden B Bosworth; Maren K Olsen; Felicia McCant; Karen M Stechuchak; Susanne Danus; Matthew J Crowley; Karen M Goldstein; Leah L Zullig; Eugene Z Oddone
Journal:  Am Heart J       Date:  2018-02-10       Impact factor: 4.749

8.  Unintentional non-adherence to chronic prescription medications: how unintentional is it really?

Authors:  Abhijit S Gadkari; Colleen A McHorney
Journal:  BMC Health Serv Res       Date:  2012-06-14       Impact factor: 2.655

9.  Characterizing weekly self-reported antihypertensive medication nonadherence across repeated occasions.

Authors:  Corrine I Voils; Heather A King; Brian Neelon; Rick H Hoyle; Bryce B Reeve; Matthew L Maciejewski; William S Yancy
Journal:  Patient Prefer Adherence       Date:  2014-05-07       Impact factor: 2.711

10.  Determinants of patient adherence: a review of systematic reviews.

Authors:  Przemyslaw Kardas; Pawel Lewek; Michal Matyjaszczyk
Journal:  Front Pharmacol       Date:  2013-07-25       Impact factor: 5.810

View more
  3 in total

1.  Trajectories of adherence to mood stabilizers in patients with bipolar disorder.

Authors:  M Bauer; T Glenn; M Alda; R Bauer; P Grof; W Marsh; S Monteith; R Munoz; N Rasgon; K Sagduyu; P C Whybrow
Journal:  Int J Bipolar Disord       Date:  2019-09-04

2.  Validity Of The Self-Reported Domains Of Subjective Extent Of Nonadherence (DOSE-Nonadherence) Scale In Comparison With Electronically Monitored Adherence To Cardiovascular Medications.

Authors:  Talea Cornelius; Corrine I Voils; Redeana C Umland; Ian M Kronish
Journal:  Patient Prefer Adherence       Date:  2019-10-03       Impact factor: 2.711

3.  Patient-Reported Reasons for Switching or Discontinuing Statin Therapy: A Mixed Methods Study Using Social Media.

Authors:  Su Golder; Davy Weissenbacher; Karen O'Connor; Sean Hennessy; Robert Gross; Graciela Gonzalez Hernandez
Journal:  Drug Saf       Date:  2022-08-07       Impact factor: 5.228

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.